EDITHAL
Dead / Abandoned — Abandoned — no statement of use filed (as of 23 Mar 2026)
What this means for you
This application is over — abandoned 23 Mar 2026. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 97352213
- Mark type
- Stylized text
- Filed
- 07 Apr 2022
- Published for opposition
- 20 Dec 2022
- Abandoned
- 23 Mar 2026
- Attorney of record
- Sarah Anne Keefe
Goods and services
- Class 042 — Scientific and technological services: Medical and scientific research, namely, conducting clinical trials for others; pharmaceutical research and development services; medical research; scientific research; providing medical and scientific research information in the field of pharmaceuticals for the treatment of Beta Thalassemia
Owner
- Editas Medicine, Inc., Cambridge, MA, US
- Editas Medicine, Inc., Cambridge, MA, US
Prosecution history
- 23 Mar 2026 — ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
- 23 Mar 2026 — ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
- 23 Mar 2026 — ABANDONMENT - NO USE STATEMENT FILED
- 23 Mar 2026 — ABANDONMENT - NO USE STATEMENT FILED
- 30 Dec 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 29 Dec 2025 — SOU EXTENSION 5 GRANTED
- 12 Aug 2025 — SOU EXTENSION 5 FILED
- 29 Dec 2025 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 12 Aug 2025 — SOU TEAS EXTENSION RECEIVED
- 14 Feb 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 14 Feb 2025 — SOU EXTENSION 4 GRANTED
- 13 Feb 2025 — SOU EXTENSION 4 FILED
- 13 Feb 2025 — SOU TEAS EXTENSION RECEIVED
- 08 Aug 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 08 Aug 2024 — SOU EXTENSION 3 GRANTED